Nucleus DNA
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, European Union
Industries Focus
- FinTech
- SaaS
- AI
- Wellness
- Data
Investor Details
Nucleus DNA is a venture capital firm investing in early-stage companies in the technology and healthcare sectors.
The firm focuses on sectors such as FinTech, SaaS, AI, data, and wellness, operating in both the United States and the European Union.
Nucleus DNA has made over 100 investments, committing more than $45 million to more than 25 companies, and has consulted for over 25 companies.
Requirements
- Early-stage companies in technology and healthcare sectors
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$24.95
-
$24.95
-
$14.95
-
$95.00
Claim this Investor
Are you an official representative of Nucleus DNA?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim